en.Wedoany.com Reported - Becton, Dickinson and Company (BD) and Suttons Creek, a BlueRidge Life Sciences company, have announced a strategic, non-exclusive collaboration aimed at helping pharmaceutical and biotechnology companies navigate the engineering, testing, quality, and regulatory complexities of combination product development more efficiently. The partnership brings together ZebraSci, BD's device-agnostic combination product testing organization, with Suttons Creek’s expertise in combination product development and systems integration, addressing the growing demands of developing complex drug-device combinations such as biologics and GLP-1 therapies.
As combination products proliferate in pharmaceutical pipelines, development teams often face vendor fragmentation and disjointed workflows. ZebraSci provides objective, data-driven testing services that support decision-making in feasibility, performance, verification, and validation activities. Suttons Creek excels in early-stage product planning and development strategy. Together, they enable greater coordination across development activities while preserving client flexibility in selecting partners and technologies.
Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems, stated: "Combination product development increasingly requires tight coordination among strategy, testing, and delivery system considerations. This collaboration brings together the complementary expertise of both companies to help clients mitigate development risks and address regulatory considerations while maintaining choice and flexibility as they advance their programs." Carolyn Dorgan, vice president of Solutions Engineering at Suttons Creek, noted: "Combination product development involves multiple vendors and siloed processes, leading to friction, delays, and regulatory risk. Our collaboration enables a more coordinated and efficient path forward."
Through this partnership, clients will benefit from earlier strategy and testing alignment, enhanced integration of the Design History File, faster decision-making, more effective partner management, objective device evaluation, and flexible vendor selection. The model supports a more predictable development pathway, reduces the likelihood of late-stage rework, and helps sponsors move efficiently from concept to market.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
